Rankin Gary O, Hong Suk-Kil, Anestis Dianne K, Ball John G, Valentovic Monica A
Department of Pharmacology, Physiology and Toxicology, Joan C. Edwards School of Medicine, Marshall University, Huntington, WV 25755, USA.
Toxicology. 2008 Mar 12;245(1-2):123-9. doi: 10.1016/j.tox.2007.12.014. Epub 2007 Dec 27.
4-Amino-2,6-dichlorophenol (ADCP) is a potent acute nephrotoxicant in vivo inducing prominent renal corticomedullary necrosis. In vitro, ADCP exposure increases lactate dehydrogenase (LDH) release from rat renal cortical slices at 0.05 mM or greater. The purpose of this study was to examine the ability of antioxidants, cytochrome P450 (CYP) and flavin adenine dinucleotide monooxygenase (FMO) activity modulators, indomethacin, glutathione and inhibitors of glutathione conjugate metabolism to attenuate ADCP cytotoxicity in vitro. Renal cortical slices prepared from untreated male Fischer 344 rats (N=4/group) were preincubated at 37 degrees C under a 100% oxygen atmosphere with an inhibitor or vehicle for 5-30 min. ADCP (0.05-0.5mM) or vehicle was added and incubations continued for 120 min. At the end of the incubation period, LDH release was measured as an index of nephrotoxicity. ADCP cytotoxicity was partially attenuated by ascorbate (1.0 or 2.0mM), but not by N,N'-diphenyl-p-phenylenediamine (DPPD), alpha-tocopherol or deferoxamine. Inhibitors of CYP (metyrapone, piperonyl butoxide and isoniazid) and FMO activity modulators (methimazole, N-octylamine) had no effect on ADCP cytotoxicity. Indomethacin or glutathione 1.0mM completely and partially blocked ADCP 0.1 and 0.5mM cytotoxicity, respectively. N-acetylcysteine, AOAA (an inhibitor of cysteine conjugate beta-lyase) and probenecid (an organic anion transport inhibitor), but not AT-125 (an inhibitor of gamma-glutamyl transferase), partially attenuated ADCP 0.1mM cytotoxicity. Overall, these results suggest that reactive metabolites may be produced from ADCP primarily via a co-oxidation-mediated mechanism. The difference in the ability of ascorbate and glutathione to attenuate ADCP-induced cytotoxicity in vitro in kidney cells could indicate that alkylation via the reactive benzoquinoneimine metabolite might be responsible for cytotoxicity rather than a free radical-mediated mechanism.
4-氨基-2,6-二氯苯酚(ADCP)是一种强效的急性肾毒性物质,在体内可导致明显的肾皮质髓质坏死。在体外,当浓度为0.05 mM或更高时,ADCP暴露会增加大鼠肾皮质切片中乳酸脱氢酶(LDH)的释放。本研究的目的是检测抗氧化剂、细胞色素P450(CYP)和黄素腺嘌呤二核苷酸单加氧酶(FMO)活性调节剂、吲哚美辛、谷胱甘肽以及谷胱甘肽共轭物代谢抑制剂在体外减轻ADCP细胞毒性的能力。从未经处理的雄性Fischer 344大鼠(每组N = 4)制备的肾皮质切片在37℃、100%氧气气氛下与抑制剂或溶剂预孵育5 - 30分钟。加入ADCP(0.05 - 0.5 mM)或溶剂,继续孵育120分钟。孵育期结束时,测量LDH释放量作为肾毒性指标。抗坏血酸(1.0或2.0 mM)可部分减轻ADCP的细胞毒性,但N,N'-二苯基对苯二胺(DPPD)、α-生育酚或去铁胺则无此作用。CYP抑制剂(甲吡酮、胡椒基丁醚和异烟肼)和FMO活性调节剂(甲巯咪唑、N-辛胺)对ADCP的细胞毒性无影响。吲哚美辛或1.0 mM谷胱甘肽分别完全和部分阻断了0.1和0.5 mM ADCP的细胞毒性。N-乙酰半胱氨酸、AOAA(半胱氨酸共轭β-裂解酶抑制剂)和丙磺舒(有机阴离子转运抑制剂)可部分减轻0.1 mM ADCP的细胞毒性,但γ-谷氨酰转移酶抑制剂AT-125则无此作用。总体而言,这些结果表明ADCP可能主要通过共氧化介导的机制产生反应性代谢产物。抗坏血酸和谷胱甘肽在体外减轻肾细胞中ADCP诱导的细胞毒性能力的差异可能表明,通过反应性苯醌亚胺代谢产物的烷基化可能是细胞毒性的原因,而非自由基介导的机制。